Press Release
<p>FERRING PHARMACEUTICALS ANNOUNCES THREE STUDENT WINNERS OF TERRY MCMORROW SCHOLARSHIPS</p>
<p><img src="/images/press_releases/terry_mcmorrow_photo.jpg" align="left" style="margin: 2px 20px 20px 2px;">
Parsippany, NJ – February 17, 2009 – Ferring Pharmaceuticals has announced the three local student winners of its Terry McMorrow Memorial Scholarships. The scholarships are based on achievement, leadership, honors, participation in school and community activities, and educational and career goals. </p>
<p>“We are very pleased to present scholarships to these promising students who demonstrate the same ideals that we recognize and reward in Ferring employees,” said Wayne Anderson, president and CEO. “Drive, dedication and pursuit of high achievement are part of our corporate culture, and the traits exemplified by our former revered employee, Terry McMorrow. We hope these scholarships will give them a good start in the pursuit of their career goals.”<img src="/images/press_releases/maegan_samuelphoto.jpg" align="right" style="margin: 20px 2px 20px 20px;"></p>
<p>A $10,000 scholarship for the most promising high school senior in Parsippany was awarded to Maegan Samuel, a student at Parsippany High School. Maegan will be attending Howard University in the fall in honor of her father, the late Dr. David M. Samuel Jr., and then pursuing a nursing degree at Howard University. In addition to her high academic achievements, Maegan plays softball, basketball and field hockey.</p>
<p>Two $5,000 scholarships were awarded to children of Ferring US employees. One was granted to Jessica Belmar of Somerset, a senior at Immaculata High School with a cumulative grade point average (GPA) of 3.72. Jessica won the 2007 New
Jersey Regional Science Fair Award for Biochemistry for her project, “The effect of calcium on tomato plants.” In addition to playing the flute and baritone horn, she participates in many extracurricular activities, including the French Honor Society and Student Council. Jessica is also involved in community programs, such as working for the Ronald McDonald House.</p>
<p><img src="/images/press_releases/jessica_belmar_photo.jpg" align="left" style="margin: 2px 20px 15px 2px;">
The other winner is Collin Berndt of Upper Saddle River, who graduated from Don Bosco Prep High School in June 2008 with a cumulative GPA of 90 (out of 100). Collin attends the University of Vermont, where he double majors in finance and environmental science. At Don Bosco, he was a member of the varsity ice hockey team and Metropolitan Junior B Travel Hockey League. His extracurricular activities include serving as a volunteer at the Fire Department and Harlem soup kitchen, and 9/11 fundraising.
<img src="/images/press_releases/colllin_berndt_scholarship_photo.jpg" align="right" style="margin: 20px 2px 20px 20px;"></p>
<p>Ferring’s scholarship fund honors the memory of Terry McMorrow, former Vice President of Finance at Ferring for nearly a decade, until he died in April 2007 at age 51. His remarkable dedication, drive, enthusiasm and achievements were an inspiration to many company employees.</p>
<p><strong>About Ferring Pharmaceuticals</strong><br/>
Ferring Pharmaceuticals, part of the Ferring Group, a privately owned, international pharmaceutical company, manufactures and markets the largest family of fertility treatments of any manufacturer in the U.S. The Company markets MENOPUR<sup>®</sup> (menotropins for injection, USP), BRAVELLE<sup>®</sup> (urofollitropin for injection, purified), REPRONEX<sup>®</sup> (menotropins for injection, USP), NOVAREL<sup>®</sup> (chorionic gonadotropin for injection, USP) and ENDOMETRIN in the U.S. to infertility specialists and their patients. Ferring also offers the Q∙CAP™, the first and only needle-free reconstitution device, for use with its fertility treatments.
Ferring’s line of orthopaedic and urology products includes EUFLEXXA™,
hyaluronic acid for pain from osteoarthritis in the knee, and DEGARELIX, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of hormonally-sensitive advanced prostate cancer. Other products include:
ACTHREL<sup>®</sup> (corticorelin ovine triflutate for injection) for the differential diagnosis of
Cushing’s syndrome; DESMOPRESSIN ACETATE in injectable and rhinal tube forms for the treatment of diabetes insipidus and primary nocturnal enuresis; and PROSED<sup>®</sup>/DS for the relief of discomfort of the lower urinary tract.
The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/ gynecology and infertility. For more information, call 888-337-7464 or visit <a href="http://www.ferringusa.com">www.ferringusa.com</a> or <a href="http://www.ferringfertility.com">www.ferringfertility.com</a>. </p>
EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used in people who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.
Important Safety Information
You should not receive this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products. You should not have an injection into the knee if you have a knee joint infection or if you have skin disease or infection around the injection site.
EUFLEXXA is only for injection into the knee performed by a qualified doctor. After you receive this injection you may need to avoid activities such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour). The safety and effectiveness of repeat treatment cycles of EUFLEXXA have not been established. The safety and effectiveness of EUFLEXXA have not been shown in people under 18 years of age.
Side effects sometimes seen when EUFLEXXA is injected into the knee joint were pain, swelling, skin irritation, and tenderness and these were generally mild and did not last long.
Please see Full Prescribing Information.
Please see Important Information for Patients.
Patient Treatment Information
PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING ANY PRODUCT DISCUSSED WITHIN THIS WEB SITE.
This website is intended only for US residents.
Euflexxa® is a registered trademark of Ferring Pharmaceuticals Inc.
